Smithers Avanza Toxicology Services has appointed Ms. Lyric Boyle as director, Business Development. The addition supports the organization’s commitment to the principles of providing accurate data, on-time, with high-touch, to each of our clients as demand for toxicology testing grows.

Lyric has over 20 years of experience in preclinical discovery and development, including safety assessments in the chemical industries.  As director, Business Development for Smithers Avanza, she will be responsible for planning and implementing a comprehensive strategy with the goal of driving sales growth and client engagement.
 
“Lyric is a respected professional with a proven ability to strengthen client relations,” said Michael Dorato, PhD, DABT, Fellow ATS, executive vice president, Smithers Avanza Toxicology Services. “Her extensive laboratory experience and contract research history enables her to provide clients with a unique understanding of study challenges and timelines.  We are very pleased to welcome Lyric Boyle to the Smithers organization.”
 
Prior to joining Smithers Avanza, Lyric served as business development director at Charles River Laboratories. Her industry experience includes Facility Head Surgeon, Technical and Study Director responsibilities in Pharmaco/Toxicokinetics, Cardiovascular Safety Pharmacology, and Quantitative Whole-Body Autoradiography.